search
Back to results

Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)] (WISER)

Primary Purpose

Breast Cancer, Obesity

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
exercise
Sponsored by
University of Minnesota
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Breast Cancer focused on measuring exercise, breast cancer, prevention, obesity, estrogen metabolism, oxidative stress, IGF-1

Eligibility Criteria

18 Years - 30 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy women
  • Self-reported menstrual cycle length of 25-35 days within the past 2 months
  • Nonsmoker
  • Sedentary (exercise < 3 times weekly within the past 6 months)
  • Intact ovaries and uterus
  • No history of gynecological problems (e.g., fibroids, endometriosis, polycystic ovary syndrome)
  • Female
  • Premenopausal
  • Body mass index 18.5 to 40
  • Stable weight (no changes ≥ 10% within the past year)

Exclusion Criteria:

  • No pregnancy or breast feeding within the past 6 months
  • No plans to become pregnant during study treatment
  • No cancer within the past 5 years except for nonmelanoma skin cancers
  • No medical condition that would prohibit participation in a vigorous program of weight-bearing aerobic exercise including, but not limited to, any of the following:

    • Fibromyalgia
    • Chronic fatigue syndrome
    • Metabolic disorders
    • Recent cardiovascular event
    • Orthopedic limitations
    • Psychiatric disorders requiring antipsychotic drugs
  • No uncontrolled hypertension (systolic blood pressure [BP] > 160 mm Hg and/or diastolic BP > 99 mm Hg)
  • No more than 7 alcoholic beverages per week
  • No injected hormonal contraceptive use within the past year
  • More than 6 months since prior use of intrauterine device
  • More than 3 months since prior oral or patch hormone contraceptives
  • No medication that would prohibit participation in a vigorous program of weight-bearing aerobic exercise

Sites / Locations

  • University of Minnesota - St. Paul Campus

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

exercise

no exercise

Arm Description

5 days per week exercise for 4 months

Outcomes

Primary Outcome Measures

Changes in urine levels of F2-isoprostanes

Secondary Outcome Measures

Changes in levels of IGF-axis proteins
Changes in insulin and glucose
Changes in estrogen metabolites
Changes in body composition

Full Information

First Posted
October 25, 2006
Last Updated
October 30, 2019
Sponsor
University of Minnesota
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00393172
Brief Title
Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]
Acronym
WISER
Official Title
Women in Steady Exercise Research (WISER)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Completed
Study Start Date
May 2006 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
March 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Minnesota
Collaborators
National Cancer Institute (NCI)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
RATIONALE: Exercising regularly may lower the risk of breast cancer. PURPOSE: This randomized clinical trial is studying how well exercise prevents breast cancer in healthy young women.
Detailed Description
OBJECTIVES: Primary Compare the changes in urine levels of a stable marker of oxidative stress (F_2-isoprostanes) in healthy young women who undergo exercise training during 4 menstrual cycles vs no exercise. Secondary Assess the changes in other metabolic factors that explain the association between physical activity and breast cancer, including: Estrogen metabolism (estrone, estradiol, estriol, 2-OHE_1, 2-OHE_2, 2-MeOHE_1, 2-MeOHE_2, 4-OHE_1, 4-OHE_2 [as well as ratios of these metabolites], insulin-like growth factor (IGF)-1 (as well as IGF-binding proteins-1, -2, and -3, insulin, glucose, body composition (including body mass index, lean mass, and body fat [DEXA scan]). OUTLINE: This is a randomized, controlled study. Participants are stratified according to baseline body fat percentage and age (18 to 24 years vs 25 to 30 years). Participants are randomized to 1 of 2 intervention arms. Arm I: Participants exercise for 30 minutes 5 times a week. The intensity of exercise is increased every 4 weeks. The exercise regimen continues for up to 4 menstrual cycles. Arm II: Participants are observed for 4 menstrual cycles. Participants in both arms undergo 24-hour collection of urine on days 7, 8, and 9 of menstrual cycles 1 and 6. F_2-isoprostanes are measured via gas chromatography-mass spectrometry (GC/MS). Estrogens are also measured by GC/MS and include E_1, E_2, E_3, 2-OHE_1, 2-OHE_2, 4-OHE_1, 4-OHE_2, 2-MeE_1, 2-MeE_2, 4-MeE_1, 4-MeE_2, and 16OHE_1. Participants undergo blood collection, body mass measurement by dual-energy x-ray absorptiometry, and a fitness assessment twice during the 6-month study. PROJECTED ACCRUAL: A total of 400 participants will be accrued.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Obesity
Keywords
exercise, breast cancer, prevention, obesity, estrogen metabolism, oxidative stress, IGF-1

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
400 (Actual)

8. Arms, Groups, and Interventions

Arm Title
exercise
Arm Type
Experimental
Arm Description
5 days per week exercise for 4 months
Arm Title
no exercise
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
exercise
Intervention Description
5 days per week exercise for 4 months
Primary Outcome Measure Information:
Title
Changes in urine levels of F2-isoprostanes
Time Frame
Before and after study
Secondary Outcome Measure Information:
Title
Changes in levels of IGF-axis proteins
Time Frame
Before and after study
Title
Changes in insulin and glucose
Time Frame
Before and after study
Title
Changes in estrogen metabolites
Time Frame
Before and after study
Title
Changes in body composition
Time Frame
Before and after study

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy women Self-reported menstrual cycle length of 25-35 days within the past 2 months Nonsmoker Sedentary (exercise < 3 times weekly within the past 6 months) Intact ovaries and uterus No history of gynecological problems (e.g., fibroids, endometriosis, polycystic ovary syndrome) Female Premenopausal Body mass index 18.5 to 40 Stable weight (no changes ≥ 10% within the past year) Exclusion Criteria: No pregnancy or breast feeding within the past 6 months No plans to become pregnant during study treatment No cancer within the past 5 years except for nonmelanoma skin cancers No medical condition that would prohibit participation in a vigorous program of weight-bearing aerobic exercise including, but not limited to, any of the following: Fibromyalgia Chronic fatigue syndrome Metabolic disorders Recent cardiovascular event Orthopedic limitations Psychiatric disorders requiring antipsychotic drugs No uncontrolled hypertension (systolic blood pressure [BP] > 160 mm Hg and/or diastolic BP > 99 mm Hg) No more than 7 alcoholic beverages per week No injected hormonal contraceptive use within the past year More than 6 months since prior use of intrauterine device More than 3 months since prior oral or patch hormone contraceptives No medication that would prohibit participation in a vigorous program of weight-bearing aerobic exercise
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mindy Kurzer
Organizational Affiliation
University of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Minnesota - St. Paul Campus
City
Saint Paul
State/Province
Minnesota
ZIP/Postal Code
55108
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
26385402
Citation
Crawford TN, Arikawa AY, Kurzer MS, Schmitz KH, Phipps WR. Cross-sectional study of factors influencing sex hormone-binding globulin concentrations in normally cycling premenopausal women. Fertil Steril. 2015 Dec;104(6):1544-51. doi: 10.1016/j.fertnstert.2015.08.040. Epub 2015 Sep 16.
Results Reference
derived
PubMed Identifier
25453541
Citation
Arikawa AY, Jakits HE, Flood A, Thomas W, Gross M, Schmitz KH, Kurzer MS. Consumption of a high glycemic load but not a high glycemic index diet is marginally associated with oxidative stress in young women. Nutr Res. 2015 Jan;35(1):7-13. doi: 10.1016/j.nutres.2014.10.005. Epub 2014 Oct 16.
Results Reference
derived
PubMed Identifier
23652373
Citation
Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):756-64. doi: 10.1158/1055-9965.EPI-12-1325.
Results Reference
derived
PubMed Identifier
21508251
Citation
O'Dougherty M, Schmitz KH, Hearst MO, Covelli M, Kurzer MS. Dual conversations: body talk among young women and their social contacts. Qual Health Res. 2011 Sep;21(9):1191-204. doi: 10.1177/1049732311405804. Epub 2011 Apr 20.
Results Reference
derived

Learn more about this trial

Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]

We'll reach out to this number within 24 hrs